1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CATALYST PHARMACEUTICALS INC
Catalyst Pharmaceuticals Inc XNAS: CPRX

Catalyst Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer, Under Radar
about

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAP...

Read More
20.19 0.25 (1.25%)
1.1M
XNAS Volume

XNAS 27 Aug, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
High Financial Strength
72.2 / 100
Valuation Score
Affordable Valuation
56.3 / 100
Momentum Score
Technically Neutral
41.7 / 100
Strong Performer, Under Radar These stocks are with good quality scores and with strong financials. They are affordably priced stocks and can give good returns View Similar Embed DVM
Analyst Price Target
34
1Yr Price target upside is 70%
7 analysts

8

S

8

W

3

O

1

T

SWOT Analysis

Catalyst Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..